AGGREGON Trademark

Trademark Overview

On Monday, March 29, 2021, a trademark application was filed for AGGREGON with the United States Patent and Trademark Office. The USPTO has given the AGGREGON trademark a serial number of 90611005. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Wednesday, August 14, 2024. This trademark is owned by XEME Biopharma, Inc.. The AGGREGON trademark is filed in the Pharmaceutical Products category with the following description:

Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals, immunotherapies and antigens
aggregon

General Information

Serial Number90611005
Word MarkAGGREGON
Filing DateMonday, March 29, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateWednesday, August 14, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 21, 2021

Trademark Statements

Goods and ServicesDrug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals, immunotherapies and antigens

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 6, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameXEME Biopharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMonmouth Junction, NJ 08852
Party NameXEME Biopharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMonmouth Junction, NJ 08852

Trademark Events

Event DateEvent Description
Thursday, April 1, 2021NEW APPLICATION ENTERED
Tuesday, July 6, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 5, 2021ASSIGNED TO EXAMINER
Friday, November 12, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 21, 2021PUBLISHED FOR OPPOSITION
Wednesday, December 1, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 21, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 15, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, August 15, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, August 17, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 15, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, August 15, 2023SOU EXTENSION 3 FILED
Tuesday, August 15, 2023SOU EXTENSION 3 GRANTED
Thursday, August 17, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 15, 2022SOU EXTENSION 1 FILED
Monday, August 15, 2022SOU EXTENSION 1 GRANTED
Wednesday, February 15, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, February 15, 2023SOU EXTENSION 2 FILED
Wednesday, February 15, 2023SOU EXTENSION 2 GRANTED
Friday, February 17, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 15, 2024SOU EXTENSION 4 FILED
Friday, February 16, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 14, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, August 14, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 14, 2024SOU EXTENSION 5 FILED
Wednesday, August 14, 2024SOU EXTENSION 5 GRANTED
Thursday, February 15, 2024SOU EXTENSION 4 GRANTED
Thursday, February 15, 2024SOU TEAS EXTENSION RECEIVED

Related Keywords

aggregon delivery range pharmaceuticals antigens wide immunotherapies facilitate agents consisting compounds